Switzerland-based insulin delivery devices maker CeQur named medtech veteran Douglas Lawrence its new CEO, replacing James Peterson.
CeQur hopes Lawrence will help navigate the company through the ramp-up of international commercial efforts for the PaQ insulin delivery device.
"Doug Lawrence has the ideal experience, perspective and leadership skills to guide CeQur as the company moves rapidly through manufacturing scale-up and into broad commercialization of the PaQ Insulin Delivery Device," CeQur chairman Erik Milledge said in prepared remarks. "Importantly, he has proven ability to successfully launch diabetes devices in multiple markets, and understands the needs of those who have diabetes, those who treat the disease, and the companies that support them."
Former CEO Peterson will stay with the company as the chairman of the board of directors.
Tal shuffles leadership in prep for pivotal trials
Boston-based Tal Medical named Jan Skvarka its new president, CEO and board member and added Dr. Ben Shapiro to its board of directors, saying the company is preparing to embark on pivotal clinical trials of its device-based treatment for psychiatric diseases.
Tal board chairman and previous acting CEO Dr. Steve Paul shifted to an executive chairman role.
Teleflex promotes international prez to Americas
Teleflex (NYSE:TFX) bumped Liam Kelly from executive vice president and president of the international division to EVP and president for the Americas.
Kinetic Concepts international SVP steps down
Kinetic Concepts, now a wholly owned subsidiary of Centaur Guernsey, announced the departure of international senior vice president Michael Mathews, who left to "pursue other opportunities."